Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Sputum procalcitonin: a potential biomarker in stable bronchiectasis

William Good, Gene Jeon, Irene Zeng, Louanne Storey, Helen Qiao, Stuart Jones, Sarah Mooney, Lata Jayaram, David Holland, Conroy Wong
ERJ Open Research 2021 7: 00285-2021; DOI: 10.1183/23120541.00285-2021
William Good
1Dept of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
2Dept of Respiratory Medicine, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William Good
  • For correspondence: William.Good@middlemore.co.nz
Gene Jeon
2Dept of Respiratory Medicine, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Zeng
3Dept of Mental Health and Addiction, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Irene Zeng
Louanne Storey
4Dept of Microbiology, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Qiao
4Dept of Microbiology, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart Jones
1Dept of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
2Dept of Respiratory Medicine, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Mooney
2Dept of Respiratory Medicine, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lata Jayaram
5Dept of Respiratory Medicine, Western Health, Melbourne, VIC, Australia
6Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Holland
7Dept of Infectious Diseases, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Conroy Wong
1Dept of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
2Dept of Respiratory Medicine, Middlemore Hospital, Counties Manukau District Health Board, Otahuhu, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Sputum procalcitonin levels in patients with bronchiectasis at visit 1 and 2.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Induced sputum procalcitonin and bacteria cultural results at visit 1. Negative indicates sputum bacteria culture negative, and positive indicates sputum bacteria culture positive.

Tables

  • Figures
  • TABLE 1

    Baseline characteristics of participants

    CharacteristicBronchiectasis groupHealthy group
    Subjects (n)3015
    Age (years)67±1143±11
    Gender (female)21 (70%)10 (67%)
    Ethnic origin (%)
     European19 (63%)12 (80%)
     Pacific6 (20%)0 (0%)
     Maori4 (13%)1 (7%)
     Other1 (4%)2 (13%)
    Spirometry
     FEV1 (L)1.87±0.623.31±0.89
     FEV1 % pred73.7±16.898.6±11.7
     FVC (L)2.71±0.894.06±1.05
     FVC % pred79.7±12.598.7±11.5
     FEV1/FVC (%)69.7±10.375.2±21.0
    C-reactive protein (mg·L−1)2.8 (2.0–3.9)¶1.6 (1.0–2.4)¶
    ESR (mm·h−1)22.7 (17.7–29.1)¶8.8 (6.4–12.0)¶
    Radiological severity#3 (2–4)+N/A
    BSI severity scoreN/A
     Mild10
     Moderate13
     Severe7

    Data are n (%) or mean±sd, unless otherwise stated. FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; ESR: erythrocyte sedimentation rate; BSI: Bronchiectasis Severity Index (range 0–24). ¶: geometric mean (95% CI); #: median (IQR); +: number of lobes with bronchiectasis.

    • TABLE 2

      Sputum procalcitonin levels

      SpontaneousInducedp-value
      Participants with bronchiectasis
       Visit one0.001¶
        Median (IQR)1.7 (1.1–4.0)1.3 (0.5–2.0)
        Geometric mean (95% CI)1.8 (1.2–2.7)1.1 (0.7–1.8)
       Visit two
        Median (IQR)2.4 (0.6–3.7)1.2 (0.7–2.4)
        Geometric mean (95% CI)1.5 (1.0–2.5)1.2 (0.8–1.6)
      Healthy participants
       Visit one
        Median (IQR)0.5 (0.2–1.2)
        Geometric mean (95% CI)0.5 (0.3–0.9)
      Procalcitonin concentration ratio between patients with bronchiectasis and healthy participants (95% CI)2.3 (1.2–4.4)#
      3.6 (1.5–8.6)+
      0.02# (0.006)+

      ¶: comparison of spontaneous sputum and induced sputum results in the bronchiectasis group using repeated measures ANOVA that pooled visit 1 and visit 2 data; #: comparison of bronchiectasis and healthy groups using mixed-effect repeated measures ANOVA that pooled visit 1 and visit 2 measurements of patients with bronchiectasis without adjusting for age and gender; +: adjusted for age and gender.

      PreviousNext
      Back to top
      Vol 7 Issue 4 Table of Contents
      ERJ Open Research: 7 (4)
      • Table of Contents
      • Index by author
      Email

      Thank you for your interest in spreading the word on European Respiratory Society .

      NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

      Enter multiple addresses on separate lines or separate them with commas.
      Sputum procalcitonin: a potential biomarker in stable bronchiectasis
      (Your Name) has sent you a message from European Respiratory Society
      (Your Name) thought you would like to see the European Respiratory Society web site.
      CAPTCHA
      This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
      Print
      Citation Tools
      Sputum procalcitonin: a potential biomarker in stable bronchiectasis
      William Good, Gene Jeon, Irene Zeng, Louanne Storey, Helen Qiao, Stuart Jones, Sarah Mooney, Lata Jayaram, David Holland, Conroy Wong
      ERJ Open Research Oct 2021, 7 (4) 00285-2021; DOI: 10.1183/23120541.00285-2021

      Citation Manager Formats

      • BibTeX
      • Bookends
      • EasyBib
      • EndNote (tagged)
      • EndNote 8 (xml)
      • Medlars
      • Mendeley
      • Papers
      • RefWorks Tagged
      • Ref Manager
      • RIS
      • Zotero
      Share
      Sputum procalcitonin: a potential biomarker in stable bronchiectasis
      William Good, Gene Jeon, Irene Zeng, Louanne Storey, Helen Qiao, Stuart Jones, Sarah Mooney, Lata Jayaram, David Holland, Conroy Wong
      ERJ Open Research Oct 2021, 7 (4) 00285-2021; DOI: 10.1183/23120541.00285-2021
      del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
      Full Text (PDF)

      Jump To

      • Article
        • Abstract
        • Abstract
        • Introduction
        • Methods
        • Results
        • Discussion
        • Footnotes
        • References
      • Figures & Data
      • Info & Metrics
      • PDF

      Subjects

      • CF and non-CF bronchiectasis
      • Tweet Widget
      • Facebook Like
      • Google Plus One

      More in this TOC Section

      Original research articles

      • Functional assay in CF organoids allows drug repurposing
      • Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
      • PERSPIRE: a cohort study
      Show more Original research articles

      Bronchiectasis

      • Bronchiectasis, immunodeficiency and treatable traits
      • Bronchiectasis therapy comparative safety
      • Outcomes and survival following LT in bronchiectasis
      Show more Bronchiectasis

      Related Articles

      Navigate

      • Home
      • Current issue
      • Archive

      About ERJ Open Research

      • Editorial board
      • Journal information
      • Press
      • Permissions and reprints
      • Advertising

      The European Respiratory Society

      • Society home
      • myERS
      • Privacy policy
      • Accessibility

      ERS publications

      • European Respiratory Journal
      • ERJ Open Research
      • European Respiratory Review
      • Breathe
      • ERS books online
      • ERS Bookshop

      Help

      • Feedback

      For authors

      • Instructions for authors
      • Publication ethics and malpractice
      • Submit a manuscript

      For readers

      • Alerts
      • Subjects
      • RSS

      Subscriptions

      • Accessing the ERS publications

      Contact us

      European Respiratory Society
      442 Glossop Road
      Sheffield S10 2PX
      United Kingdom
      Tel: +44 114 2672860
      Email: journals@ersnet.org

      ISSN

      Online ISSN: 2312-0541

      Copyright © 2023 by the European Respiratory Society